Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Heliyon ; 10(6): e27777, 2024 Mar 30.
Article in English | MEDLINE | ID: mdl-38560671

ABSTRACT

The control of human-machine interfaces (HMIs), such as motorized wheelchairs, has been widely investigated using biopotentials produced by electrochemical processes in the human body. However, many studies in this field sometimes overlook crucial factors like special users' needs, who often have inadequate muscle mass and strength, and paresis needed to operate a wheelchair. This study proposes a novel solution: an economical, universally compatible, and user-centric manual-to-powered wheelchair conversion kit. The powered wheelchair is operated using a hybrid control system integrating electroencephalogram (EEG) and electromyography (EMG), utilizing an LSTM network. It uses a low-cost electroencephalogram (EEG) headset and a wearable electromyography (EMG) electrode armband to solve these constraints. The proposed system comprised three crucial objectives: the development of an EEG-based user attentive detection system, an EMG-based navigation system, and a transform conventional wheelchair into a powered wheelchair. Human test subjects were utilized to evaluate the proposed system, and the study complied with accepted ethical guidelines. We selected four EEG features (p < 0.023) for the attentive detection system and six EMG features (p < 0.037) to detect navigation intentions. User attentive detection was achieved at 83.33 (±0.34) %, while the navigation intention system produced 86.67 (±0.52) % accuracy. The overall system was successful in reaching an accuracy rate of 85.0 (±0.19) % and a weighted average precision of 0.89. After the dataset was trained using an LSTM network, the overall accuracy produced was 97.3 (±0.5) %, higher than the accuracy produced by the Quadratic SVM classifier. By giving older and disabled people a more convenient way to use powered wheelchairs, this research helps to build ergonomic and cost-effective biopotential-based HMIs, enhancing their quality of life.

2.
Bioengineering (Basel) ; 11(3)2024 Mar 21.
Article in English | MEDLINE | ID: mdl-38534569

ABSTRACT

Speech impairments often emerge as one of the primary indicators of Parkinson's disease (PD), albeit not readily apparent in its early stages. While previous studies focused predominantly on binary PD detection, this research explored the use of deep learning models to automatically classify sustained vowel recordings into healthy controls, mild PD, or severe PD based on motor symptom severity scores. Popular convolutional neural network (CNN) architectures, VGG and ResNet, as well as vision transformers, Swin, were fine-tuned on log mel spectrogram image representations of the segmented voice data. Furthermore, the research investigated the effects of audio segment lengths and specific vowel sounds on the performance of these models. The findings indicated that implementing longer segments yielded better performance. The models showed strong capability in distinguishing PD from healthy subjects, achieving over 95% precision. However, reliably discriminating between mild and severe PD cases remained challenging. The VGG16 achieved the best overall classification performance with 91.8% accuracy and the largest area under the ROC curve. Furthermore, focusing analysis on the vowel /u/ could further improve accuracy to 96%. Applying visualization techniques like Grad-CAM also highlighted how CNN models focused on localized spectrogram regions while transformers attended to more widespread patterns. Overall, this work showed the potential of deep learning for non-invasive screening and monitoring of PD progression from voice recordings, but larger multi-class labeled datasets are needed to further improve severity classification.

3.
Cancers (Basel) ; 15(16)2023 Aug 17.
Article in English | MEDLINE | ID: mdl-37627172

ABSTRACT

Accurate classification of cancer images plays a crucial role in diagnosis and treatment planning. Deep learning (DL) models have shown promise in achieving high accuracy, but their performance can be influenced by variations in Hematoxylin and Eosin (H&E) staining techniques. In this study, we investigate the impact of H&E stain normalization on the performance of DL models in cancer image classification. We evaluate the performance of VGG19, VGG16, ResNet50, MobileNet, Xception, and InceptionV3 on a dataset of H&E-stained cancer images. Our findings reveal that while VGG16 exhibits strong performance, VGG19 and ResNet50 demonstrate limitations in this context. Notably, stain normalization techniques significantly improve the performance of less complex models such as MobileNet and Xception. These models emerge as competitive alternatives with lower computational complexity and resource requirements and high computational efficiency. The results highlight the importance of optimizing less complex models through stain normalization to achieve accurate and reliable cancer image classification. This research holds tremendous potential for advancing the development of computationally efficient cancer classification systems, ultimately benefiting cancer diagnosis and treatment.

4.
Curr Med Imaging ; 17(12): 1460-1472, 2021.
Article in English | MEDLINE | ID: mdl-33504310

ABSTRACT

AIMS: To prevent Alzheimer's disease (AD) from progressing to dementia, early prediction and classification of AD are important and they play a crucial role in medical image analysis. BACKGROUND: In this study, we employed a transfer learning technique to classify magnetic resonance (MR) images using a pre-trained convolutional neural network (CNN). OBJECTIVE: To address the early diagnosis of AD, we employed a computer-assisted technique, specifically the deep learning (DL) model, to detect AD. METHODS: In particular, we classified Alzheimer's disease (AD), mild cognitive impairment (MCI), and normal control (NC) subjects using whole slide two-dimensional (2D) images. To illustrate this approach, we made use of state-of-the-art CNN base models, i.e., the residual networks Res- Net-101, ResNet-50, and ResNet-18, and compared their effectiveness in identifying AD. To evaluate this approach, an AD Neuroimaging Initiative (ADNI) dataset was utilized. We also showed uniqueness by using MR images selected only from the central slice containing left and right hippocampus regions to evaluate the models. RESULTS: All three models used randomly split data in the ratio of 70:30 for training and testing. Among the three, ResNet-101 showed 98.37% accuracy, better than the other two ResNet models, and performed well in multiclass classification. The promising results emphasize the benefit of using transfer learning, specifically when the dataset is low. CONCLUSION: From this study, we know that transfer learning helps to overcome DL problems mainly when the data available is insufficient to train a model from scratch. This approach is highly advantageous in medical image analysis to diagnose diseases like AD.


Subject(s)
Alzheimer Disease , Cognitive Dysfunction , Alzheimer Disease/diagnostic imaging , Cognitive Dysfunction/diagnostic imaging , Humans , Machine Learning , Magnetic Resonance Imaging , Neuroimaging
5.
Diagnostics (Basel) ; 12(1)2021 Dec 22.
Article in English | MEDLINE | ID: mdl-35054182

ABSTRACT

Biomarker identification is very important to differentiate the grade groups in the histopathological sections of prostate cancer (PCa). Assessing the cluster of cell nuclei is essential for pathological investigation. In this study, we present a computer-based method for cluster analyses of cell nuclei and performed traditional (i.e., unsupervised method) and modern (i.e., supervised method) artificial intelligence (AI) techniques for distinguishing the grade groups of PCa. Two datasets on PCa were collected to carry out this research. Histopathology samples were obtained from whole slides stained with hematoxylin and eosin (H&E). In this research, state-of-the-art approaches were proposed for color normalization, cell nuclei segmentation, feature selection, and classification. A traditional minimum spanning tree (MST) algorithm was employed to identify the clusters and better capture the proliferation and community structure of cell nuclei. K-medoids clustering and stacked ensemble machine learning (ML) approaches were used to perform traditional and modern AI-based classification. The binary and multiclass classification was derived to compare the model quality and results between the grades of PCa. Furthermore, a comparative analysis was carried out between traditional and modern AI techniques using different performance metrics (i.e., statistical parameters). Cluster features of the cell nuclei can be useful information for cancer grading. However, further validation of cluster analysis is required to accomplish astounding classification results.

6.
Curr Med Imaging Rev ; 16(1): 27-35, 2020.
Article in English | MEDLINE | ID: mdl-31989891

ABSTRACT

BACKGROUND: In this study, we used a convolutional neural network (CNN) to classify Alzheimer's disease (AD), mild cognitive impairment (MCI), and normal control (NC) subjects based on images of the hippocampus region extracted from magnetic resonance (MR) images of the brain. METHODS: The datasets used in this study were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI). To segment the hippocampal region automatically, the patient brain MR images were matched to the International Consortium for Brain Mapping template (ICBM) using 3D-Slicer software. Using prior knowledge and anatomical annotation label information, the hippocampal region was automatically extracted from the brain MR images. RESULTS: The area of the hippocampus in each image was preprocessed using local entropy minimization with a bi-cubic spline model (LEMS) by an inhomogeneity intensity correction method. To train the CNN model, we separated the dataset into three groups, namely AD/NC, AD/MCI, and MCI/NC. The prediction model achieved an accuracy of 92.3% for AD/NC, 85.6% for AD/MCI, and 78.1% for MCI/NC. CONCLUSION: The results of this study were compared to those of previous studies, and summarized and analyzed to facilitate more flexible analyses based on additional experiments. The classification accuracy obtained by the proposed method is highly accurate. These findings suggest that this approach is efficient and may be a promising strategy to obtain good AD, MCI and NC classification performance using small patch images of hippocampus instead of whole slide images.


Subject(s)
Alzheimer Disease/classification , Alzheimer Disease/diagnostic imaging , Hippocampus/diagnostic imaging , Image Interpretation, Computer-Assisted/methods , Magnetic Resonance Imaging , Neural Networks, Computer , Brain Mapping , Case-Control Studies , Cognitive Dysfunction/classification , Cognitive Dysfunction/diagnostic imaging , Datasets as Topic , Humans
7.
Cancers (Basel) ; 11(12)2019 Dec 04.
Article in English | MEDLINE | ID: mdl-31817111

ABSTRACT

Microscopic biopsy images are coloured in nature because pathologists use the haematoxylin and eosin chemical colour dyes for biopsy examinations. In this study, biopsy images are used for histological grading and the analysis of benign and malignant prostate tissues. The following PCa grades are analysed in the present study: benign, grade 3, grade 4, and grade 5. Biopsy imaging has become increasingly important for the clinical assessment of PCa. In order to analyse and classify the histological grades of prostate carcinomas, pixel-based colour moment descriptor (PCMD) and gray-level co-occurrence matrix (GLCM) methods were used to extract the most significant features for multilayer perceptron (MLP) neural network classification. Haar wavelet transformation was carried out to extract GLCM texture features, and colour features were extracted from RGB (red/green/blue) colour images of prostate tissues. The MANOVA statistical test was performed to select significant features based on F-values and P-values using the R programming language. We obtained an average highest accuracy of 92.7% using level-1 wavelet texture and colour features. The MLP classifier performed well, and our study shows promising results based on multi-feature classification of histological sections of prostate carcinomas.

8.
Curr Med Imaging Rev ; 15(7): 689-698, 2019.
Article in English | MEDLINE | ID: mdl-32008517

ABSTRACT

BACKGROUND: We propose a classification method for Alzheimer's disease (AD) based on the texture of the hippocampus, which is the organ that is most affected by the onset of AD. METHODS: We obtained magnetic resonance images (MRIs) of Alzheimer's patients from the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. This dataset consists of image data for AD, mild cognitive impairment (MCI), and normal controls (NCs), classified according to the cognitive condition. In this study, the research methods included image processing, texture analyses, and deep learning. Firstly, images were acquired for texture analyses, which were then re-spaced, registered, and cropped with Gabor filters applied to the resulting image data. In the texture analyses, we applied the 3-dimensional (3D) gray-level co-occurrence (GLCM) method to evaluate the textural features of the image, and used Fisher's coefficient to select the appropriate features for classification. In the last stage, we implemented a deep learning multi-layer perceptron (MLP) model, which we divided into three types, namely, AD-MCI, AD-NC, and MCI-NC. RESULTS: We used this model to assess the accuracy of the proposed method. The classification accuracy of the proposed deep learning model was confirmed in the cases of AD-MCI (72.5%), ADNC (85%), and MCI-NC (75%). We also evaluated the results obtained using a confusion matrix, support vector machine (SVM), and K-nearest neighbor (KNN) classifier and analyzed the results to objectively verify our model. We obtained the highest accuracy of 85% in the AD-NC. CONCLUSION: The proposed model was at least 6-19% more accurate than the SVM and KNN classifiers, respectively. Hence, this study confirms the validity and superiority of the proposed method, which can be used as a diagnostic tool for early Alzheimer's diagnosis.


Subject(s)
Alzheimer Disease/classification , Brain/diagnostic imaging , Deep Learning , Alzheimer Disease/diagnostic imaging , Brain/pathology , Case-Control Studies , Cognitive Dysfunction/diagnostic imaging , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Neuroimaging , Reproducibility of Results
9.
Curr Med Imaging Rev ; 15(7): 699-709, 2019.
Article in English | MEDLINE | ID: mdl-32008518

ABSTRACT

BACKGROUND: In this study, we investigated the effect of hippocampal subfield atrophy on the development of Alzheimer's disease (AD) by analyzing baseline magnetic resonance images (MRI) and images collected over a one-year follow-up period. Previous studies have suggested that morphological changes to the hippocampus are involved in both normal ageing and the development of AD. The volume of the hippocampus is an authentic imaging biomarker for AD. However, the diverse relationship of anatomical and complex functional connectivity between different subfields implies that neurodegenerative disease could lead to differences between the atrophy rates of subfields. Therefore, morphometric measurements at subfield-level could provide stronger biomarkers. METHODS: Hippocampal subfield atrophies are measured using MRI scans, taken at multiple time points, and shape-based normalization to a Montreal neurological institute (MNI) ICBM 152 nonlinear atlas. Ninety subjects were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI), and divided equally into Healthy Controls (HC), AD, and mild cognitive impairment (MCI) groups. These subjects underwent serial MRI studies at three time-points: baseline, 6 months and 12 months. RESULTS: We analyzed the subfield-level hippocampal morphometric effects of normal ageing and AD based on radial distance mapping and volume measurements. We identified a general trend and observed the largest hippocampal subfield atrophies in the AD group. Atrophy of the bilateral CA1, CA2- CA4 and subiculum subfields was higher in the case of AD than in MCI and HC. We observed the highest rate of reduction in the total volume of the hippocampus, especially in the CA1 and subiculum regions, in the case of MCI. CONCLUSION: Our findings show that hippocampal subfield atrophy varies among the three study groups.


Subject(s)
Aging/pathology , Alzheimer Disease/pathology , Hippocampus/pathology , Aged , Aged, 80 and over , Alzheimer Disease/diagnostic imaging , Atrophy , Case-Control Studies , Cognitive Dysfunction/diagnostic imaging , Cognitive Dysfunction/pathology , Disease Progression , Female , Follow-Up Studies , Hippocampus/diagnostic imaging , Humans , Magnetic Resonance Imaging , Male , Neuroimaging
10.
Curr Med Imaging Rev ; 15(2): 161-169, 2019.
Article in English | MEDLINE | ID: mdl-31975662

ABSTRACT

BACKGROUND: In this study, we investigated the fusion of texture and morphometric features as a possible diagnostic biomarker for Alzheimer's Disease (AD). METHODS: In particular, we classified subjects with Alzheimer's disease, Mild Cognitive Impairment (MCI) and Normal Control (NC) based on texture and morphometric features. Currently, neuropsychiatric categorization provides the ground truth for AD and MCI diagnosis. This can then be supported by biological data such as the results of imaging studies. Cerebral atrophy has been shown to correlate strongly with cognitive symptoms. Hence, Magnetic Resonance (MR) images of the brain are important resources for AD diagnosis. In the proposed method, we used three different types of features identified from structural MR images: Gabor, hippocampus morphometric, and Two Dimensional (2D) and Three Dimensional (3D) Gray Level Co-occurrence Matrix (GLCM). The experimental results, obtained using a 5-fold cross-validated Support Vector Machine (SVM) with 2DGLCM and 3DGLCM multi-feature fusion approaches, indicate that we achieved 81.05% ±1.34, 86.61% ±1.25 correct classification rate with 95% Confidence Interval (CI) falls between (80.75-81.35) and (86.33-86.89) respectively, 83.33%±2.15, 84.21%±1.42 sensitivity and 80.95%±1.52, 85.00%±1.24 specificity in our classification of AD against NC subjects, thus outperforming recent works found in the literature. For the classification of MCI against AD, the SVM achieved a 76.31% ± 2.18, 78.95% ±2.26 correct classification rate, 75.00% ±1.34, 76.19%±1.84 sensitivity and 77.78% ±1.14, 82.35% ±1.34 specificity. RESULTS AND CONCLUSION: The results of the third experiment, with MCI against NC, also showed that the multiclass SVM provided highly accurate classification results. These findings suggest that this approach is efficient and may be a promising strategy for obtaining better AD, MCI and NC classification performance.


Subject(s)
Alzheimer Disease/diagnostic imaging , Cognitive Dysfunction/diagnostic imaging , Hippocampus/diagnostic imaging , Support Vector Machine , Aged , Algorithms , Alzheimer Disease/classification , Atrophy/diagnostic imaging , Atrophy/pathology , Brain/diagnostic imaging , Brain/pathology , Case-Control Studies , Cognitive Dysfunction/classification , Confidence Intervals , Diagnosis, Differential , Hippocampus/pathology , Humans , Middle Aged , Normal Distribution , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...